InMed Pharmaceuticals Inc.
INM· Nasdaq
InMed Pharmaceuticals Inc.
- Last sale
- Oct 1, 2026 · -1.49%
- Market cap
- $7.25M
- 5.49M shares
- Filings
- 501
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-06-30 | $4,942,633 | reported | |
| FY 2024 | 2024-06-30 | $4,597,730 | reported | |
| FY 2023 | 2023-06-30 | $4,135,561 | reported | |
| FY 2022 | 2022-06-30 | $1,365,755 revised | reported | |
| FY 2021 | 2021-06-30 | $1,904,013 | reported |
InMed Pharmaceuticals Inc. · CIK 1728328 · Engraved from SEC EDGAR
